0
Original Research: ANTITHROMBOTIC THERAPY |

Clinical Outcome of Patients With Upper-Extremity Deep Vein Thrombosis*: Results From the RIETE Registry

Francisco José Muñoz, MD, PhD; Patrick Mismetti, MD; Renzo Poggio, MD; Reina Valle, MD; Manuel Barrón, MD; María Guil, MD; Manuel Monreal, MD, PhD; for the RIETE Investigators
Author and Funding Information

Affiliations: *From the Department of Internal Medicine (Dr. Muñoz), Hospital de Mollet, Mollet del Vallès, Barcelona, Spain; Department of Internal Medicine (Dr. Mismetti), Hospital Bellevue, Saint-Etienne, France; Internal Medicine Thrombosis Center (Dr. Poggio), Hospital Galliera, Genoa, Italy; Department of Internal Medicine (Dr. Valle), Hospital Sierrallana, Torrelavega, Cantabria, Spain; Department of Pneumology (Dr. Barrón), Complejo Hospitalario San Millán y San Pedro, Logroño, La Rioja, Spain; Department of Internal Medicine (Dr. Guil), Hospital de la Axarquía, Vélez, Málaga, Spain; and Department of Internal Medicine (Dr. Monreal), Hospital Germans Trias i Pujol, Barcelona, Spain.,  A full list of RIETE investigators is given in the Appendix.

Correspondence to: Manuel Monreal, MD, PhD, Professor of Medicine. Serviicio de Medicina Interna, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain; e-mail: mmonreal.germanstrias@gencat.net


Affiliations: *From the Department of Internal Medicine (Dr. Muñoz), Hospital de Mollet, Mollet del Vallès, Barcelona, Spain; Department of Internal Medicine (Dr. Mismetti), Hospital Bellevue, Saint-Etienne, France; Internal Medicine Thrombosis Center (Dr. Poggio), Hospital Galliera, Genoa, Italy; Department of Internal Medicine (Dr. Valle), Hospital Sierrallana, Torrelavega, Cantabria, Spain; Department of Pneumology (Dr. Barrón), Complejo Hospitalario San Millán y San Pedro, Logroño, La Rioja, Spain; Department of Internal Medicine (Dr. Guil), Hospital de la Axarquía, Vélez, Málaga, Spain; and Department of Internal Medicine (Dr. Monreal), Hospital Germans Trias i Pujol, Barcelona, Spain.,  A full list of RIETE investigators is given in the Appendix.


Chest. 2008;133(1):143-148. doi:10.1378/chest.07-1432
Text Size: A A A
Published online

Background: There is little information on the clinical outcome of patients with upper-extremity deep vein thrombosis (DVT).

Methods: RIETE is an ongoing registry of consecutive patients with objectively confirmed, symptomatic, acute DVT or pulmonary embolism (PE). In this analysis, we analyzed the demographic characteristics, treatment, and 3-month outcome of all patients with DVT in the arm.

Results: Of the 11,564 DVT patients enrolled, 512 patients (4.4%) had arm DVT. They presented less often with clinically overt PE (9.0% vs 29%; odds ratio, 0.24; 95% confidence interval [CI], 0.18 to 0.33) than those with lower-limb DVT, but their 3-month outcome was similar. Of the 512 patients with arm DVT, 196 patients (38%) had cancer and 228 patients (45%) had catheter-related DVT. During follow-up, those with cancer DVT had an increased incidence of major bleeding (4.1% vs 0.9%; odds ratio, 4.4; 95% CI, 1.2 to 21), recurrent venous thromboembolism (6.1% vs 2.8%; odds ratio, 2.2; 95% CI, 0.91 to 5.6; p = 0.04), and death (22% vs 3.5%; odds ratio, 7.8; 95% CI, 4.0 to 16). Thirty patients had the composite event of recurrent DVT, symptomatic PE, or major bleeding. They were significantly older, more often had cancer, and presented more frequently with symptomatic PE on hospital admission. On multivariate analysis, only cancer patients with arm DVT had an increased risk for the composite event (odds ratio, 3.0; 95% CI, 1.4 to 6.4).

Conclusions: At presentation, patients with arm DVT have less often clinically overt PE than those with lower-limb DVT, but their 3-month outcome is similar. Among patients with arm DVT, those with cancer have the worse outcome.


Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543